Mirae Asset Global Investments’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,657,557	Closed	-$1.47M	–	2622
2022 Q4	$1.47M	Buy	1,657,557 +146,776	+10%	+$195K	﹤0.01%	1299
2022 Q3	$2.37M	Buy	1,510,781 +175,710	+13%	+$399K	0.01%	1067
2022 Q2	$2.68M	Buy	1,335,071 +429,224	+47%	+$742K	0.01%	1048
2022 Q1	$2.11M	Sell	905,847 -149,396	-14%	-$466K	﹤0.01%	1146
2021 Q4	$4.91M	Buy	1,055,243 +268,257	+34%	+$1.67M	0.01%	890
2021 Q3	$6M	Buy	786,986 +154,327	+24%	+$1.31M	0.02%	789
2021 Q2	$6.13M	Buy	632,659 +126,084	+25%	+$1M	0.02%	767
2021 Q1	$4.19M	Buy	506,575 +231,840	+84%	+$2.45M	0.01%	768
2020 Q4	$1.88M	Buy	274,735 +144,342	+111%	+$1.16M	0.01%	950
2020 Q3	$1.45M	Buy	130,393 +41,683	+47%	+$381K	0.01%	861
2020 Q2	$557K	Buy	88,710 +45,588	+106%	+$175K	﹤0.01%	1104
2020 Q1	$79K	Buy	43,122 +4,813	+13%	+$13.9K	﹤0.01%	1390
2019 Q4	$129K	Sell	38,309 -11,482	-23%	-$27.4K	﹤0.01%	1455
2019 Q3	$107K	Buy	49,791 +36,801	+283%	+$85.8K	﹤0.01%	1410
2019 Q2	$35K	Buy	+12,990	New	+$46.7K	﹤0.01%	1385